GTII Stock Overview
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for GTII from our risk checks.
Green Thumb Industries Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$14.05 |
| 52 Week High | CA$21.50 |
| 52 Week Low | CA$10.44 |
| Beta | 1.44 |
| 11 Month Change | -8.29% |
| 3 Month Change | -12.52% |
| 1 Year Change | -12.35% |
| 33 Year Change | -58.37% |
| 5 Year Change | 3.46% |
| Change since IPO | 56.98% |
Recent News & Updates
Recent updates
Green Thumb Industries Inc.'s (CSE:GTII) P/S Is On The Mark
Sep 15
Green Thumb Industries Inc. Just Recorded A 174% EPS Beat: Here's What Analysts Are Forecasting Next
May 11Green Thumb Industries Inc. (CSE:GTII) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
Apr 12Green Thumb Industries Inc.'s (CSE:GTII) Intrinsic Value Is Potentially 53% Above Its Share Price
Mar 28Does Green Thumb Industries (CSE:GTII) Have A Healthy Balance Sheet?
Feb 29Subdued Growth No Barrier To Green Thumb Industries Inc.'s (CSE:GTII) Price
Dec 19Is Green Thumb Industries (CSE:GTII) Using Too Much Debt?
Aug 31Green Thumb Industries (CSE:GTII) Takes On Some Risk With Its Use Of Debt
May 28These 4 Measures Indicate That Green Thumb Industries (CSE:GTII) Is Using Debt Reasonably Well
Feb 27With EPS Growth And More, Green Thumb Industries (CSE:GTII) Makes An Interesting Case
Feb 05Green Thumb Industries (CSE:GTII) Seems To Use Debt Quite Sensibly
Nov 27If EPS Growth Is Important To You, Green Thumb Industries (CSE:GTII) Presents An Opportunity
Oct 17Is Green Thumb Industries (CSE:GTII) Using Too Much Debt?
Aug 09With EPS Growth And More, Green Thumb Industries (CSE:GTII) Makes An Interesting Case
Jul 19Does Green Thumb Industries (CSE:GTII) Have A Healthy Balance Sheet?
Apr 23Earnings Tell The Story For Green Thumb Industries Inc. (CSE:GTII)
Mar 03Green Thumb Industries (CSE:GTII) Has A Pretty Healthy Balance Sheet
Dec 24These 4 Measures Indicate That Green Thumb Industries (CSE:GTII) Is Using Debt Reasonably Well
Sep 18Here's Why Green Thumb Industries Inc.'s (CSE:GTII) CEO May Deserve A Raise
Jun 21We Think That There Are Issues Underlying Green Thumb Industries' (CSE:GTII) Earnings
Mar 25Results: Green Thumb Industries Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Shareholder Returns
| GTII | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 7.3% | 5.7% | 3.3% |
| 1Y | -12.4% | -23.7% | 13.1% |
Return vs Industry: GTII exceeded the Canadian Pharmaceuticals industry which returned -23.3% over the past year.
Return vs Market: GTII underperformed the Canadian Market which returned 13% over the past year.
Price Volatility
| GTII volatility | |
|---|---|
| GTII Average Weekly Movement | 7.9% |
| Pharmaceuticals Industry Average Movement | 10.5% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CA Market | 16.8% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: GTII has not had significant price volatility in the past 3 months.
Volatility Over Time: GTII's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 4,500 | Ben Kovler | www.gtigrows.com |
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.
Green Thumb Industries Inc. Fundamentals Summary
| GTII fundamental statistics | |
|---|---|
| Market cap | CA$3.31b |
| Earnings (TTM) | CA$89.04m |
| Revenue (TTM) | CA$1.51b |
37.2x
P/E Ratio2.2x
P/S RatioIs GTII overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GTII income statement (TTM) | |
|---|---|
| Revenue | US$1.11b |
| Cost of Revenue | US$537.64m |
| Gross Profit | US$571.94m |
| Other Expenses | US$506.43m |
| Earnings | US$65.52m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.28 |
| Gross Margin | 51.55% |
| Net Profit Margin | 5.90% |
| Debt/Equity Ratio | 17.7% |
How did GTII perform over the long term?
See historical performance and comparison